Our researchers coordinate and provide leadership for the development of clinical phase I and phase II treatment protocols, utilizing agents identified by the basic/ translational component of the Michael Cuccione Childhood Cancer Research Program and the Childhood Cancer & Blood Research Group.
Dr. Kirk Schultz leads the clinical research team. He is an experienced clinical investigator with a primary focus on bone marrow transplantation (BMT) and care for complicated acute lymphoblastic leukemia patients and oversees the clinical research activities of the Pediatric Oncology Program.
He has been involved in the development, performance and leadership of 19 clinical protocols. He also serves as Chair of the Canadian Bone Marrow Transplantation (BMT) Group’s Clinical Trials Network and is the Chair-Elect of the international Pediatric Bone Marrow Transplantation Consortium, and his laboratory is a reference laboratory for both groups. He chairs an international phase III trial in acute lymphoblastic leukemia.
The Childhood Cancer & Blood Research Group and the Clinical Research Program are the designated Tumour Group for Pediatrics at BC Children's Hospital, BC Cancer Agency and University of British Columbia. BC Children's Hospital and BC Cancer Agency are agencies of the Provincial Health Services Authority.